Figure 5From: Management of cardiovascular risk factors with pioglitazone combination therapies in type 2 diabetes: an observational cohort studyProportion of patients distributed according to the risk ranges for cardiovascular events and vascular complications estimated by the EDPG, related to lipid profile (A-D) and glycemic status (E-F).Back to article page